Session: Biomanufacturing for Biopharmaceuticals

Biomanufacturing has become an emerging industry of strategic importance worldwide and is one of the key technology areas identified by the US Advanced Manufacturing Partnership (AMP) as an appropriate target for public-private investment to support advances in manufacturing and U.S. competitiveness. The development of advanced biomanufacturing technologies consortium will foster and support the fast growing biomanufacturing industry and establish sustained leadership of the US in the area. This session organized by the Biomanufacturing Science and Technology Consortium (BSTC) team will feature experts from government, academia and industry and seek to: 1) discuss the challenges and drivers of biomanufacturing in upstream, downstream and drug product processing, 2) identify the major scientific/technological, operational and regulatory barriers in the biopharmaceutical industry, and 3) define a pre-collaborative work space for companies, academia and regulatory authorities.